SEC Form 4 · accession 0001144204-16-119909
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ming Yang
Officer — Chief Financial Officer
Period of report
Aug 15, 2016
Accepted (ET)
Aug 17, 2016 · 7:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2016 | S | 21,092 | $124.32 | D | 24,782 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 21,092 shares of common stock (the "Sold Common Stock") sold on the open market at a weighted average price of $124.32 per share on August 15, 2016. The Reporting Person intends to use a portion of the proceeds from the sales of the Sold Common Stock to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $124.00 to $125.13, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 2.